Registry Search

8,240 Clinical Drug Overviews

Medication	Therapeutic Class	Generic Mapping	Safety
DALMANE Comprehensive clinical and safety monograph for DALMANE (DALMANE).	Benzodiazepine Hypnotic	DALMANE	caution
DALVANCE Comprehensive clinical and safety monograph for DALVANCE (DALVANCE).	Non-Nucleoside Reverse Transcriptase Inhibitor	DALVANCE	caution
DANAZOL Comprehensive clinical and safety monograph for DANAZOL (DANAZOL).	Androgen/Antigonadotropin	DANAZOL	caution
DANOCRINE Comprehensive clinical and safety monograph for DANOCRINE (DANOCRINE).	Androgen/Antigonadotropin	DANOCRINE	caution
DANTRIUM Comprehensive clinical and safety monograph for DANTRIUM (DANTRIUM).	Skeletal Muscle Relaxant	DANTRIUM	caution
DANTROLENE SODIUM CNS depressants and estrogens may enhance hepatotoxicity Can cause hepatotoxicity and muscle weakness.	Skeletal Muscle Relaxant	DANTROLENE SODIUM	safe
DANYELZA Comprehensive clinical and safety monograph for DANYELZA (DANYELZA).	Monoclonal Antibody Antineoplastic	DANYELZA	caution
DANZITEN Comprehensive clinical and safety monograph for DANZITEN (DANZITEN).	Androgen/Antigonadotropin	DANZITEN	caution
DAPAGLIFLOZIN Comprehensive clinical and safety monograph for DAPAGLIFLOZIN (DAPAGLIFLOZIN).	SGLT2 Inhibitor	DAPAGLIFLOZIN	caution
DAPAGLIFLOZIN AND METFORMIN Alcohol and contrast dye can increase risk of lactic acidosis Can cause lactic acidosis a rare but serious metabolic complication.	Biguanide	DAPAGLIFLOZIN AND METFORMIN	safe
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE Alcohol and contrast dye can increase risk of lactic acidosis Can cause lactic acidosis a rare but serious metabolic complication.	Biguanide	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	safe
DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE Strong CYP3A4/5 inhibitors may increase levels May cause hypersensitivity reactions including anaphylaxis.	DPP-4 Inhibitor	DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE	safe
DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE Strong CYP3A4/5 inhibitors may increase levels May cause hypersensitivity reactions including anaphylaxis.	DPP-4 Inhibitor	DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE	safe
DAPIPRAZOLE HYDROCHLORIDE Comprehensive clinical and safety monograph for DAPIPRAZOLE HYDROCHLORIDE (DAPIPRAZOLE HYDROCHLORIDE).	Atypical Antipsychotic	DAPIPRAZOLE HYDROCHLORIDE	caution
DAPSONE Rifampin decreases levels trimethoprim increases levels Can cause hemolytic anemia and methemoglobinemia especially in G6PD deficiency.	Antibacterial	DAPSONE	caution
DAPTOMYCIN HMG-CoA reductase inhibitors may increase risk of myopathy May cause myopathy and rhabdomyolysis monitor CPK levels.	Lipopeptide Antibiotic	DAPTOMYCIN	safe
DAPTOMYCIN IN 0.9% SODIUM CHLORIDE No significant drug interactions Can cause hypernatremia and fluid overload.	Electrolyte	DAPTOMYCIN IN 0.9% SODIUM CHLORIDE	safe
DAPZURA RT Comprehensive clinical and safety monograph for DAPZURA RT (DAPZURA RT).	SGLT2 Inhibitor	DAPZURA RT	caution
DARANIDE Comprehensive clinical and safety monograph for DARANIDE (DARANIDE).	Carbonic Anhydrase Inhibitor	DARANIDE	caution
DARAPRIM Comprehensive clinical and safety monograph for DARAPRIM (DARAPRIM).	Antiprotozoal Agent	DARAPRIM	caution
DARBID Comprehensive clinical and safety monograph for DARBID (DARBID).	Anticholinergic	DARBID	caution
DARICON Comprehensive clinical and safety monograph for DARICON (DARICON).	Anticholinergic	DARICON	caution
DARIFENACIN Comprehensive clinical and safety monograph for DARIFENACIN (DARIFENACIN).	Antimuscarinic	DARIFENACIN	caution
DARIFENACIN HYDROBROMIDE Comprehensive clinical and safety monograph for DARIFENACIN HYDROBROMIDE (DARIFENACIN HYDROBROMIDE).	Antimuscarinic	DARIFENACIN HYDROBROMIDE	caution
DARTISLA ODT Comprehensive clinical and safety monograph for DARTISLA ODT (DARTISLA ODT).	Adenosine A2A Receptor Antagonist	DARTISLA ODT	caution
DARUNAVIR Strong CYP3A4 inducers (eg rifampin) are contraindicated as they significantly decrease levels May cause severe skin reactions and hepatotoxicity.	Protease Inhibitor	DARUNAVIR	safe
DARUNAVIR AND RITONAVIR A strong inhibitor of CYP3A4 affecting many drugs Can cause GI intolerance hepatotoxicity and pancreatitis.	Protease Inhibitor	DARUNAVIR AND RITONAVIR	safe
DARUNAVIR ETHANOLATE Strong CYP3A4 inducers (eg rifampin) are contraindicated as they significantly decrease levels May cause severe skin reactions and hepatotoxicity.	Protease Inhibitor	DARUNAVIR ETHANOLATE	safe
DARVOCET Comprehensive clinical and safety monograph for DARVOCET (DARVOCET).	Opioid Analgesic Combination	DARVOCET	caution
DARVOCET A500 Comprehensive clinical and safety monograph for DARVOCET A500 (DARVOCET A500).	Opioid Analgesic Combination	DARVOCET A500	caution
DARVOCET-N 100 Comprehensive clinical and safety monograph for DARVOCET-N 100 (DARVOCET-N 100).	Opioid Analgesic	DARVOCET-N 100	caution
DARVOCET-N 50 Comprehensive clinical and safety monograph for DARVOCET-N 50 (DARVOCET-N 50).	Opioid Analgesic	DARVOCET-N 50	caution
DARVON Comprehensive clinical and safety monograph for DARVON (DARVON).	Opioid Analgesic	DARVON	caution
DARVON COMPOUND Comprehensive clinical and safety monograph for DARVON COMPOUND (DARVON COMPOUND).	Opioid Analgesic Combination	DARVON COMPOUND	caution
DARVON COMPOUND-65 Comprehensive clinical and safety monograph for DARVON COMPOUND-65 (DARVON COMPOUND-65).	Opioid Analgesic Combination	DARVON COMPOUND-65	caution
DARVON W/ ASA Comprehensive clinical and safety monograph for DARVON W/ ASA (DARVON W/ ASA).	Opioid Analgesic Combination	DARVON W/ ASA	caution
DARVON-N Comprehensive clinical and safety monograph for DARVON-N (DARVON-N).	Opioid Analgesic	DARVON-N	caution
DARVON-N W/ ASA Comprehensive clinical and safety monograph for DARVON-N W/ ASA (DARVON-N W/ ASA).	Opioid Analgesic Combination	DARVON-N W/ ASA	caution
DARZALEX Comprehensive clinical and safety monograph for DARZALEX (DARZALEX).	CD38-directed Monoclonal Antibody	DARZALEX	caution
DARZALEX FASPRO Comprehensive clinical and safety monograph for DARZALEX FASPRO (DARZALEX FASPRO).	CD38-directed Monoclonal Antibody	DARZALEX FASPRO	caution
DASATINIB Antacids and H2 blockers decrease absorption May cause severe myelosuppression and fluid retention.	Kinase Inhibitor	DASATINIB	avoid
DASETTA 1/35 Comprehensive clinical and safety monograph for DASETTA 1/35 (DASETTA 1/35).	Oral Contraceptive	DASETTA 1/35	caution
DASETTA 7/7/7 Comprehensive clinical and safety monograph for DASETTA 7/7/7 (DASETTA 7/7/7).	Oral Contraceptive	DASETTA 7/7/7	caution
DATROWAY Comprehensive clinical and safety monograph for DATROWAY (DATROWAY).	Trop-2-directed Antibody-Drug Conjugate	DATROWAY	caution
DATSCAN Comprehensive clinical and safety monograph for DATSCAN (DATSCAN).	Diagnostic Radiopharmaceutical (Dopamine Transporter Imaging Agent)	DATSCAN	caution
DAUNORUBICIN HYDROCHLORIDE Other cardiotoxic drugs (eg trastuzumab) increase risk Can cause severe and irreversible cardiotoxicity and myelosuppression.	Anthracycline Antibiotic	DAUNORUBICIN HYDROCHLORIDE	avoid
DAUNOXOME Comprehensive clinical and safety monograph for DAUNOXOME (DAUNOXOME).	Anthracycline Antineoplastic	DAUNOXOME	caution
DAURISMO Comprehensive clinical and safety monograph for DAURISMO (DAURISMO).	Hedgehog Pathway Inhibitor	DAURISMO	caution
DAWNZERA (AUTOINJECTOR) Comprehensive clinical and safety monograph for DAWNZERA (AUTOINJECTOR) (DAWNZERA (AUTOINJECTOR)).	Unknown	DAWNZERA (AUTOINJECTOR)	caution
DAXXIFY Comprehensive clinical and safety monograph for DAXXIFY (DAXXIFY).	Botulinum Toxin (Neuromuscular Blocker)	DAXXIFY	caution

Showing 1751 - 1800 of 8245

Previous Next